<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ACM</journal-id><journal-title-group><journal-title>Advances in Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2161-8712</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/ACM.2021.115331</article-id><article-id pub-id-type="publisher-id">ACM-42666</article-id><article-categories><subj-group subj-group-type="heading"><subject>ACM20210500000_20233548.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  肌内效贴布治疗肱骨外上髁炎疗效的系统评价和Meta分析
  Systematic Evaluation and Meta-Analysis of the Efficacy of Kensiotaping in the Treatment of External Humeral Epicondylitis
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>黄</surname><given-names>琬云</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>宋</surname><given-names>红宇</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>贾</surname><given-names>梦真</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>张</surname><given-names>孝刚</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>姜</surname><given-names>影</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>滨州医学院，山东 烟台</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>08</day><month>05</month><year>2021</year></pub-date><volume>11</volume><issue>05</issue><fpage>2296</fpage><lpage>2305</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  目的：系统评价肌内效贴布对肱骨外上髁炎的疗效。方法：方法计算机检索PubMed、web of science、Pedro、Cochrane library、万方、维普、中国学术杂志(CNKI)、中国生物医学相关文献数据库(CBM)从我国大学校园建库到2020年11月关于肌内效贴布技术治疗肱骨外上上炎的随机调查与对照实证实践研究(RCT)。将被纳入的文献在网络上进行了筛选，资料的提取，质量评估和风险评价后，使用RevMan5.4软件对其进行了Meta分析。结果：共纳入13项RCT研究，共计706例受试者。Meta分析结果显示：肌内效贴与无刺激组VAS比较，合并效应量MD = −1.17，95% CI (−3.06, 0.73)，Z = 1.21，P = 0.23，疗效可能优于无刺激组；肌内效贴组和假刺激组VAS比较，超声波亚组合并效应量MD = −2.02，95% CI (−2.38, −1.65)，Z = 10.82，P &lt; 0.00001，体外冲击波亚组合并效应量MD = −0.20，95% CI (−0.39, −0.01)，Z = 2.11，P = 0.03，疗效优于假治疗组；肌内效组和理疗组VAS比较，合并效应量MD = 0.16，95% CI (0.03, 0.28)，Z = 2.47，P = 0.01，疗效不如理疗组；肌内效组和理疗组PRTEE比较，合并效应量MD = 0.92，95% CI (−0.44, 2.29)，Z = 1.33，P = 0.18，疗效可能优于理疗组。结论：肌内效贴布在一定程度上可以改善患者疼痛，在改善功能障碍方面不明显。
   Objective: To systematically evaluate the effect of kensiotaping on external humeral epicondylitis. Methods: Randomized controlled trials (RCTs) of kensiotaping in the treatment of lateral epicondylitis of humerus were searched from PubMed, Web of Science, Pedro, Cochrane Library, Wanfang, Weipu, Chinese academic journals (CNKI) and China Biomechanical Literature Database (CBM) by computer from establishment to November 2020. The included literatures were screened, data extraction, quality assessment and risk assessment, and Meta-analysis was performed using Revman 5.4 software. Results: A total of 13 RCT studies with 706 subjects were included. The results of Meta-analysis showed that the combined effect size of VAS, MD = −1.17, 95% CI (−3.06, 0.73), Z = 1.21, P = 0.23, VAS comparison showed that kensiotaping was better that of the non- stimulation group. The combined effect size of ultrasonic subgroup was MD = −2.02, 95% CI (−2.38, −1.65), Z = 10.82, P &lt; 0.00001, and the combined effect size of extracorporeal shock wave subgroup was MD = −0.20, 95% CI (−0.39, −0.01), Z = 2.11, P = 0.03, which showed that kensiotaping was better than that of sham group in VAS. VAS comparison between the kensiotaping group and the physiotherapy group showed that the combined effect size MD = 0.16, 95% CI (0.03, 0.28), Z = 2.47, P = 0.01, the efficacy was inferior to that of the physiotherapy group. The combined effect size MD = 0.92, 95% CI (−0.44, 2.29), Z = 1.33, P = 0.18 in PRTEE between kensiotaping group and physiotherapy group, suggesting that the efficacy of PRTEE may better than that of physiotherapy group. Conclusion: Kensiotaping can improve pain in patients to some extent, but it is not obvious in improving dysfunction.
 
</p></abstract><kwd-group><kwd>肌内效贴布，肱骨外上髁炎，网球肘，Meta分析, Kensiotaping</kwd><kwd> External Humerus Epicondylitis</kwd><kwd> Tennis Elbow</kwd><kwd> Meta Analysis</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>摘要</title><p>目的：系统评价肌内效贴布对肱骨外上髁炎的疗效。方法：方法计算机检索PubMed、web of science、Pedro、Cochrane library、万方、维普、中国学术杂志(CNKI)、中国生物医学相关文献数据库(CBM)从我国大学校园建库到2020年11月关于肌内效贴布技术治疗肱骨外上上炎的随机调查与对照实证实践研究(RCT)。将被纳入的文献在网络上进行了筛选，资料的提取，质量评估和风险评价后，使用RevMan5.4软件对其进行了Meta分析。结果：共纳入13项RCT研究，共计706例受试者。Meta分析结果显示：肌内效贴与无刺激组VAS比较，合并效应量MD = −1.17，95% CI (−3.06, 0.73)，Z = 1.21，P = 0.23，疗效可能优于无刺激组；肌内效贴组和假刺激组VAS比较，超声波亚组合并效应量MD = −2.02，95% CI (−2.38, −1.65)，Z = 10.82，P &lt; 0.00001，体外冲击波亚组合并效应量MD = −0.20，95% CI (−0.39, −0.01)，Z = 2.11，P = 0.03，疗效优于假治疗组；肌内效组和理疗组VAS比较，合并效应量MD = 0.16，95% CI (0.03, 0.28)，Z = 2.47，P = 0.01，疗效不如理疗组；肌内效组和理疗组PRTEE比较，合并效应量MD = 0.92，95% CI (−0.44, 2.29)，Z = 1.33，P = 0.18，疗效可能优于理疗组。结论：肌内效贴布在一定程度上可以改善患者疼痛，在改善功能障碍方面不明显。</p></sec><sec id="s2"><title>关键词</title><p>肌内效贴布，肱骨外上髁炎，网球肘，Meta分析</p></sec><sec id="s3"><title>Systematic Evaluation and Meta-Analysis of the Efficacy of Kensiotaping in the Treatment of External Humeral Epicondylitis</title><p>Wanyun Huang, Hongyu Song, Mengzhen Jia, Xiaogang Zhang, Ying Jiang<sup>*</sup></p><p>Binzhou Medical University, Yantai Shandong</p><p><img src="//html.hanspub.org/file/40-1572197x5_hanspub.png" /></p><p>Received: Apr. 25<sup>th</sup>, 2021; accepted: May 8<sup>th</sup>, 2021; published: May 27<sup>th</sup>, 2021</p><p><img src="//html.hanspub.org/file/40-1572197x6_hanspub.png" /></p></sec><sec id="s4"><title>ABSTRACT</title><p>Objective: To systematically evaluate the effect of kensiotaping on external humeral epicondylitis. Methods: Randomized controlled trials (RCTs) of kensiotaping in the treatment of lateral epicondylitis of humerus were searched from PubMed, Web of Science, Pedro, Cochrane Library, Wanfang, Weipu, Chinese academic journals (CNKI) and China Biomechanical Literature Database (CBM) by computer from establishment to November 2020. The included literatures were screened, data extraction, quality assessment and risk assessment, and Meta-analysis was performed using Revman 5.4 software. Results: A total of 13 RCT studies with 706 subjects were included. The results of Meta-analysis showed that the combined effect size of VAS, MD = −1.17, 95% CI (−3.06, 0.73), Z = 1.21, P = 0.23, VAS comparison showed that kensiotaping was better that of the non- stimulation group. The combined effect size of ultrasonic subgroup was MD = −2.02, 95% CI (−2.38, −1.65), Z = 10.82, P &lt; 0.00001, and the combined effect size of extracorporeal shock wave subgroup was MD = −0.20, 95% CI (−0.39, −0.01), Z = 2.11, P = 0.03, which showed that kensiotaping was better than that of sham group in VAS. VAS comparison between the kensiotaping group and the physiotherapy group showed that the combined effect size MD = 0.16, 95% CI (0.03, 0.28), Z = 2.47, P = 0.01, the efficacy was inferior to that of the physiotherapy group. The combined effect size MD = 0.92, 95% CI (−0.44, 2.29), Z = 1.33, P = 0.18 in PRTEE between kensiotaping group and physiotherapy group, suggesting that the efficacy of PRTEE may better than that of physiotherapy group. Conclusion: Kensiotaping can improve pain in patients to some extent, but it is not obvious in improving dysfunction.</p><p>Keywords:Kensiotaping, External Humerus Epicondylitis, Tennis Elbow, Meta Analysis</p><disp-formula id="hanspub.42666-formula79"><graphic xlink:href="//html.hanspub.org/file/40-1572197x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2021 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY 4.0).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/40-1572197x8_hanspub.png" /> <img src="//html.hanspub.org/file/40-1572197x9_hanspub.png" /></p></sec><sec id="s5"><title>1. 引言</title><p>肱骨外上关节炎(简称网球肘)是一种临床常见的一种肘部关节病，表现为网球肘前臂和后伸肌的起点区疼痛；疼痛的出现主要来源于由前臂延长肌肉重复使用力所致而造成的慢性疲劳 [<xref ref-type="bibr" rid="hanspub.42666-ref1">1</xref>]，该疾病多见于反复旋转前臂及经常做旋腕动作的人群，如网球运动员、教师等 [<xref ref-type="bibr" rid="hanspub.42666-ref2">2</xref>]。在一般人群中的平均患病率约1%~3%，在一般和高危人群中的平均患病率约分别为15% [<xref ref-type="bibr" rid="hanspub.42666-ref3">3</xref>]。肱骨外上髁炎，特征是疼痛感强烈，疼痛位置是肘关节外侧，严重时无法提握物品，在阴雨天时疼痛感有加重倾向，生活质量差 [<xref ref-type="bibr" rid="hanspub.42666-ref4">4</xref>]。目前在用于我国医疗临床上的适用于中医治疗新型网球肘的主要手段和治疗方法及其种类也还是有很多，传统的现代医学卫生技术治疗方面主要手段包括传统中药材的外敷、中医药材的熏蒸冲洗、针灸、推拿局部按摩、小针刀等，西医疗法治疗的新型网球肘主要手段包括各种行为心理干预、康复以及运动肌力锻炼、物理注射治疗和各种局部血液灌注或者局部封闭性注射治疗 [<xref ref-type="bibr" rid="hanspub.42666-ref5">5</xref>]。</p><p>肌内效贴扎法是一种新型的处理治疗技术，主要具备有助于缓解疼痛、减轻体内水肿、支撑和放松柔韧性组织、矫正姿态等作用，可以长期贴扎并维护效果，贴扎的同时还可以对肌肉进行多种机械活动和各种身体功能性的锻炼，不会影响贴扎的正常使用 [<xref ref-type="bibr" rid="hanspub.42666-ref6">6</xref>]。但是其治疗效果仍然存在一定的争议，本项研究的主要目标是通过科学性的系统评价和客观的Meta分析，对应用肌内效贴布法去治疗肱骨外上膜炎的效果进行非主观性、科学性地评价，更深层次的目的为以后的医院临床应用和治疗工作提供了便捷性的参考依据。</p></sec><sec id="s6"><title>2. 资料与方法</title><sec id="s6_1"><title>2.1. 纳入与排除标准</title><sec id="s6_1_1"><title>2.1.1. 纳入标准</title><p>① 研究对象：肱骨外上膜炎症的患者，年龄、病程、性别和临床案例数据来源可能不限；② 干预措施：术后治疗组可以给予肌内效贴布治疗(贴扎的方式、连续时间和治疗疗程长度不限)或者肌内效贴布联合其他术后治疗；对照组没有经过任何治疗(无任何刺激)或给予其他治疗。③ 结局标准依据：主要的结局参考标准依据为肘关节视觉模拟评价分数(visual analogue scale, VAS)，次要的结局指标为肘关节视觉功能相关的量表(Patient-Rated Tennis Elbow Evaluation, PRTEE)。④ 研究项目设计：随机的对照实验，语言局限中文和英文。</p></sec><sec id="s6_1_2"><title>2.1.2. 排除标准</title><p>① 原始资料缺失且被索取不成功；② 治疗方法和措施不明确；③ 重复出版。</p></sec></sec><sec id="s6_2"><title>2.2. 检索策略</title><p>计算机信息网络系统可以实时检索所有Cochrane Library、Pubmed、Webof Science、Pedro、中国国家学术论文杂志(CNKI)、中国国家生物医学技术相关文献数据库(CBM)、维普医学信息数据资源管理系统(VIP)和万方数据库。收集了自建立书库到2020年11月之间所有出版的RCT。</p><p>以CNKI为例，中文的检索策略为：</p><p>#1 “肌内效贴布”或“肌能贴”或“肌贴”或“软组织贴扎”</p><p>#2 “肱骨外上髁炎”或“网球肘”</p><p>#3 #1和#2</p><p>以PubMed为例，英文检索策略为：</p><p>#1 taping * OR kinesio taping</p><p>#2 tennis elbow * OR lateral epicondylitis</p><p>#3 #1 AND #2</p></sec><sec id="s6_3"><title>2.3. 文献筛选和资料提取</title><p>由2位独立的科学研究机构工作人员通过仔细地审核阅读文章标题和全文摘要，初步分析筛选并找出了可能符合我们所需的纳入文献标准的相关文献，进一步通过审核阅读全文，根据文献排除率的标准要求来逐步筛选不可能符合要求的相关文献。然后我们通过Excel2010制作一份关于相关研究资料的基本提取文件格式：① 这份基本资料，包括第一个研究工作者的真实姓名、第二个成果发表人的日期、国家、样品研发数量、干预治疗措施、对照使用药物、治疗持续期限、疗程和最终起始结局所得及需要随机测量的持续时间；② 需要了解相关患者的具体相关疾病信息，包括患者年龄、性别和相关疾病的各个起始发展阶段；③ 结局偏倚指标，包括主要的起始结局偏倚指标(VAS)和次要的最终结局倾倚指标(PRTEE)；④ 偏袒倾倚性质的风险评估，包括随机检测数据的是否产生、分配是否隐蔽、研究工作人员和其他受试者的双盲法同时执行、结局随机数据的相对完整性、选择性不当地无法报告相关研究成果和其它性的偏倚，出现分歧时由第3名研究人员参与并达成共识。</p></sec><sec id="s6_4"><title>2.4. 质量评价</title><p>采用Cochrane系统的推荐指导标准 [<xref ref-type="bibr" rid="hanspub.42666-ref7">7</xref>] 对RCT偏倚风险进行了评价，包含7个主要的方面。① 随机方案的形成；② 分配隐藏；③ 盲法(适合于受试人员及治疗执行人员)；④ 盲目评判(最终结局的评价人)；⑤ 不完全的数据；⑥ 具有选择性的报告；⑦ 其它。将偏倚风险的严重程度划分为“低风险”、“高风险”、“不清楚”(本文没有提供充分足够可以做出分析的资料)。同时使用了一种经过改良的Jadad量表来评价文献的质量，1~3分认为较低的质量，4~7分认为较高的质量。</p></sec><sec id="s6_5"><title>2.5. 统计学分析</title><p>采用Cochrane协作网提供的RevMan5.4进行meta分析。采用均数差(MD)和95%CI表示连续性变量。使用非平均数差(MD)和95%CI来直接表示一个具有连续性的函数变量。通过采用χ<sup>2</sup>检验和通过I<sup>2</sup>值对被直接纳入的两个研究间共同影响数据进行了异质性综合检验，若大于P &gt; 0.10，I<sup>2</sup> &lt; 50%，认为被直接纳入的两个研究间共同影响数据是否完全具有异质性，采用固定运动效应综合模型分析方法转而进行Meta综合分析；结果若大于P ≤ 0.10，I<sup>2</sup> ≥ 50%，则可以认为被直接纳入的两个研究之间是否存在一种异质性，采用随机固定效应分析模型；如果无法准确地分析判断表现出异质性的数据来源和影响数据不能完全进行合并时，则不进行Meta分析采用描述性分析。</p></sec></sec><sec id="s7"><title>3. 结果</title><sec id="s7_1"><title>3.1. 文献检索结果</title><p>数据库初检索后获得533篇文献，删除重复的文献后余348篇。在通过阅读题目与摘要和整篇文章的阅读之后，将其中13篇被列为综合性的参考。本文筛选工作流程图和研究成果，见图1。</p><p>图1. 文献筛选流程</p><sec id="s7_1_1"><title>3.1.1. 纳入研究的一般情况</title><p>纳入文献的基本特征见表1 [<xref ref-type="bibr" rid="hanspub.42666-ref8">8</xref>] - [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>]。所有纳入文献均经过综合性考虑，其中6篇为英文 [<xref ref-type="bibr" rid="hanspub.42666-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref13">13</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref17">17</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref18">18</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref19">19</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>]，7篇为中文 [<xref ref-type="bibr" rid="hanspub.42666-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref10">10</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref11">11</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref15">15</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref16">16</xref>]。1个纳入文献的研究在伊朗开展 [<xref ref-type="bibr" rid="hanspub.42666-ref12">12</xref>]，5个纳入文献的研究在土耳其开展 [<xref ref-type="bibr" rid="hanspub.42666-ref13">13</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref17">17</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref18">18</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref19">19</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>]，其余纳入文献的研究均在中国开展 [<xref ref-type="bibr" rid="hanspub.42666-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref10">10</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref11">11</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref15">15</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref16">16</xref>]。所有的纳入文献均为已发表的论文 [<xref ref-type="bibr" rid="hanspub.42666-ref8">8</xref>] - [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>]。</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Basic characteristics of the included studie</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >纳入研究</th><th align="center" valign="middle" >国家</th><th align="center" valign="middle" >n (实验组/对照组)</th><th align="center" valign="middle" >年龄(岁，实验组/对照组)</th><th align="center" valign="middle" >病程(月，实验组/对照组)</th><th align="center" valign="middle" >干预措施(实验组/对照组)</th><th align="center" valign="middle" >结局指标</th></tr></thead><tr><td align="center" valign="middle" >张娥铿等 (2016) [<xref ref-type="bibr" rid="hanspub.42666-ref8">8</xref>]</td><td align="center" valign="middle" >中国</td><td align="center" valign="middle" >35/35</td><td align="center" valign="middle" >(54 &#177; 6)</td><td align="center" valign="middle" >(0.17~2.7)/(0.1~2.87)</td><td align="center" valign="middle" >KT + 音频电 + US/音频电 + US</td><td align="center" valign="middle" >VAS, PRTEE</td></tr><tr><td align="center" valign="middle" >余波等 (2016) [<xref ref-type="bibr" rid="hanspub.42666-ref9">9</xref>]</td><td align="center" valign="middle" >中国</td><td align="center" valign="middle" >13/10</td><td align="center" valign="middle" >(41.32 &#177; 10.25)/(40.60 &#177; 11.91)</td><td align="center" valign="middle" >(12.61 &#177; 5.83)/(11.74 &#177; 4.95)</td><td align="center" valign="middle" >KT + ESWT/ESWT</td><td align="center" valign="middle" >VAS, VSS</td></tr><tr><td align="center" valign="middle" >李范强等 (2017) [<xref ref-type="bibr" rid="hanspub.42666-ref10">10</xref>]</td><td align="center" valign="middle" >中国</td><td align="center" valign="middle" >30/30</td><td align="center" valign="middle" >(41.4 &#177; 4.9)/(42.6 &#177; 5.5)</td><td align="center" valign="middle" >(12.51 &#177; 5.47)/(11.95 &#177; 6.51)</td><td align="center" valign="middle" >KT + ESWT/ESWT</td><td align="center" valign="middle" >VAS, VSS</td></tr><tr><td align="center" valign="middle" >丁丹阳等(2017) [<xref ref-type="bibr" rid="hanspub.42666-ref11">11</xref>]</td><td align="center" valign="middle" >中国</td><td align="center" valign="middle" >21/21</td><td align="center" valign="middle" >(43.45 &#177; 6.71)/(42.87 &#177; 7.63)</td><td align="center" valign="middle" >(1.43 &#177; 0.25)/(1.97 &#177; 0.7)</td><td align="center" valign="middle" >KT + US/US</td><td align="center" valign="middle" >VAS, DASH问卷</td></tr><tr><td align="center" valign="middle" >Hassan Shakeri (2017) [<xref ref-type="bibr" rid="hanspub.42666-ref12">12</xref>]</td><td align="center" valign="middle" >伊朗</td><td align="center" valign="middle" >15/15</td><td align="center" valign="middle" >(37.6 &#177; 11.56)/(31.62 &#177; 11.43)</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >KT/安慰剂组(KT无弹性)</td><td align="center" valign="middle" >VAS, PPT, gripstrength, DASH问卷</td></tr><tr><td align="center" valign="middle" >P. Borman (2017) [<xref ref-type="bibr" rid="hanspub.42666-ref13">13</xref>]</td><td align="center" valign="middle" >土耳其</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >47.53</td><td align="center" valign="middle" >未说明</td><td align="center" valign="middle" >KT/类固醇注射、低强度激光治疗</td><td align="center" valign="middle" >VAS, Maudley测试，Cozen’s测试，Mills试验的阳性率</td></tr><tr><td align="center" valign="middle" >张娥铿等(2017) [<xref ref-type="bibr" rid="hanspub.42666-ref14">14</xref>]</td><td align="center" valign="middle" >中国</td><td align="center" valign="middle" >25/75</td><td align="center" valign="middle" >(40.68 &#177; 7.44)</td><td align="center" valign="middle" >(0.19 &#177; 0.05)、(0.19 &#177; 0.06)/(0.19 &#177; 0.04)</td><td align="center" valign="middle" >KT、KT + 理疗(US)/理疗组(US)</td><td align="center" valign="middle" >PRTEE, PPT</td></tr><tr><td align="center" valign="middle" >肖少华等(2019) [<xref ref-type="bibr" rid="hanspub.42666-ref15">15</xref>]</td><td align="center" valign="middle" >中国</td><td align="center" valign="middle" >15/14</td><td align="center" valign="middle" >(21.72 &#177; 2.76)</td><td align="center" valign="middle" >1~24</td><td align="center" valign="middle" >KT + ESWT/ESWT</td><td align="center" valign="middle" >VAS，Mills征</td></tr><tr><td align="center" valign="middle" >张禄菊(2019) [<xref ref-type="bibr" rid="hanspub.42666-ref16">16</xref>]</td><td align="center" valign="middle" >中国</td><td align="center" valign="middle" >25/25</td><td align="center" valign="middle" >(29.15 &#177; 9.73)/(28.12 &#177; 8.31)</td><td align="center" valign="middle" >(1.01 &#177; 0.29)/(0.99 &#177; 0.3)</td><td align="center" valign="middle" >KT + 局部常规治疗(US)/局部常规治疗(US)</td><td align="center" valign="middle" >VAS，肘关节的肌围度</td></tr><tr><td align="center" valign="middle" >Fatmanur Aybala Ko&#231;ak (2019) [<xref ref-type="bibr" rid="hanspub.42666-ref17">17</xref>]</td><td align="center" valign="middle" >土耳其</td><td align="center" valign="middle" >28/56</td><td align="center" valign="middle" >(43.06 &#177; 11.19)</td><td align="center" valign="middle" >(1.36 &#177; 0.9)</td><td align="center" valign="middle" >KT/类固醇注射，KT + 类固醇注射</td><td align="center" valign="middle" >VAS，PPT，Q-DASH问卷，李克特量表</td></tr><tr><td align="center" valign="middle" >TGuler (2020) [<xref ref-type="bibr" rid="hanspub.42666-ref18">18</xref>]</td><td align="center" valign="middle" >土耳其</td><td align="center" valign="middle" >20/20</td><td align="center" valign="middle" >(42.6 &#177; 8.4)</td><td align="center" valign="middle" >&lt;3</td><td align="center" valign="middle" >KT/ESWT</td><td align="center" valign="middle" >VAS，strengthscore，Q-DASH问卷</td></tr><tr><td align="center" valign="middle" >Nihal Teze l (2020) [<xref ref-type="bibr" rid="hanspub.42666-ref19">19</xref>]</td><td align="center" valign="middle" >土耳其</td><td align="center" valign="middle" >27/21</td><td align="center" valign="middle" >(48.4 &#177; 10.6)/(46.8 &#177; 5.1)</td><td align="center" valign="middle" >3~60/3~48</td><td align="center" valign="middle" >KT/假对照组(KT无弹性)</td><td align="center" valign="middle" >VAS, PRTEE, gripstrength, wristextensorstrength</td></tr><tr><td align="center" valign="middle" >TOzmen (2020) [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>]</td><td align="center" valign="middle" >土耳其</td><td align="center" valign="middle" >40.US (n = 13), ESWT (n = 14), and KT (n = 13)</td><td align="center" valign="middle" >(48.38 &#177; 10.35)</td><td align="center" valign="middle" >≥3</td><td align="center" valign="middle" >KT/US，ESWT</td><td align="center" valign="middle" >VAS, PRTEE</td></tr></tbody></table></table-wrap><p>表1. 纳入研究的基本特征</p><p>注：肌内效贴布(kinesiotaping, KT)；超声波疗法(ultrasonic therapy, US)；体外冲击波疗法(Extracorporeal shock wave therapy, ESWT)；视觉模拟评分(Visual Analogue Scale, VAS)；肘关节功能相关量表(Patient-Rated Tennis Elbow Evaluation, PRTEE)，压力疼痛阈值(pressure pain threshold, PPT)，Verhaar评价标准(Verhaa standard scale, VSS)，快速的手臂、肩部和手部残疾问卷(quick disability of the arm, Shoulder and hand questionnaire, Q-DASH)。</p></sec><sec id="s7_1_2"><title>3.1.2. 干预措施及疗程</title><p>在所纳入的13篇文献中，13篇研究设计为实验组与对照组，实验组为使用肌内效贴布或在常规康复治疗基础上给予肌内效贴，对照组不使用肌内效贴或给予安慰剂贴布(假刺激)或类固醇注射。3篇研究 [<xref ref-type="bibr" rid="hanspub.42666-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref17">17</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>] 设计为三组，分别为肌内效组、肌内效联合超声波组、超声波组和KT组、超声波组、体外冲击波组和肌内效组、肌内效联合类固醇注射组、类固醇注射组。在所纳入研究的干预疗程中，最小疗程2周，最大疗程10周。</p></sec><sec id="s7_1_3"><title>3.1.3. 结局指标</title><p>13篇文献均明确说明了结局评价标准，采用较多的量表是VAS和PRTEE。其中，结局指标里12个研究采用VAS [<xref ref-type="bibr" rid="hanspub.42666-ref8">8</xref>] - [<xref ref-type="bibr" rid="hanspub.42666-ref13">13</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref15">15</xref>] - [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>]，4个研究采用PRTEE [<xref ref-type="bibr" rid="hanspub.42666-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref19">19</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>]，4个研究采用DASH问卷 [<xref ref-type="bibr" rid="hanspub.42666-ref11">11</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref16">16</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref17">17</xref>]。</p></sec></sec><sec id="s7_2"><title>3.2. 纳入研究的质量评价</title><p>纳入的13篇文献均为RCT，其中10篇文献 [<xref ref-type="bibr" rid="hanspub.42666-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref10">10</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref11">11</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref15">15</xref>] - [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>] 主要采用了随机数码表法，3篇文献 [<xref ref-type="bibr" rid="hanspub.42666-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref13">13</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref14">14</xref>] 则是利用电脑来产生随机的数码表。在本文中分配的隐藏性问题方面，2篇文献 [<xref ref-type="bibr" rid="hanspub.42666-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref18">18</xref>] 作了详细的表述，其余部分文献都没有作出任何描述。盲法实施方面，较难真正做到盲法的实施者和活动参与人员是双盲，未明确提及实际使用的盲法共有4篇 [<xref ref-type="bibr" rid="hanspub.42666-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref10">10</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref11">11</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref16">16</xref>]，其余的文献均有明确报道这些盲法的具体实施。纳入研究的偏倚性风险评估和各个偏倚性所占的百分比见于图2、图3。按照改良后的Jadad评分标准，高品质文献7篇 [<xref ref-type="bibr" rid="hanspub.42666-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref13">13</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref15">15</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref18">18</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref19">19</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>]，低品质文献6篇 [<xref ref-type="bibr" rid="hanspub.42666-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref10">10</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref11">11</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref16">16</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref17">17</xref>]。见表2。</p><p>图2. 偏倚风险评估</p><p>图3. 各偏倚所占比例</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Quality assessment results of included studie</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >纳入研究</th><th align="center" valign="middle" >随机序列的产生</th><th align="center" valign="middle" >随机化隐藏</th><th align="center" valign="middle" >盲法</th><th align="center" valign="middle" >撤出与退出</th><th align="center" valign="middle" >改良的Jadad评分</th></tr></thead><tr><td align="center" valign="middle" >张娥铿等 (2016) [<xref ref-type="bibr" rid="hanspub.42666-ref8">8</xref>]</td><td align="center" valign="middle" >不清楚，随机试验但未描述方法</td><td align="center" valign="middle" >不恰当</td><td align="center" valign="middle" >不清楚</td><td align="center" valign="middle" >描述了撤出或退出的数目或理由</td><td align="center" valign="middle" >3分</td></tr><tr><td align="center" valign="middle" >余波等 (2016) [<xref ref-type="bibr" rid="hanspub.42666-ref9">9</xref>]</td><td align="center" valign="middle" >不清楚，随机试验但未描述方法</td><td align="center" valign="middle" >不清楚，只表明随机数字表法</td><td align="center" valign="middle" >不恰当</td><td align="center" valign="middle" >描述了撤出或退出的数目或理由</td><td align="center" valign="middle" >3分</td></tr><tr><td align="center" valign="middle" >李范强等 (2017) [<xref ref-type="bibr" rid="hanspub.42666-ref10">10</xref>]</td><td align="center" valign="middle" >不清楚，随机试验但未描述方法</td><td align="center" valign="middle" >不清楚，只表明随机数字表法</td><td align="center" valign="middle" >不恰当</td><td align="center" valign="middle" >描述了撤出或退出的数目或理由</td><td align="center" valign="middle" >3分</td></tr><tr><td align="center" valign="middle" >丁丹阳等(2017) [<xref ref-type="bibr" rid="hanspub.42666-ref11">11</xref>]</td><td align="center" valign="middle" >不清楚，随机试验但未描述方法</td><td align="center" valign="middle" >不清楚，只表明随机数字表法</td><td align="center" valign="middle" >不恰当</td><td align="center" valign="middle" >描述了撤出或退出的数目或理由</td><td align="center" valign="middle" >3分</td></tr><tr><td align="center" valign="middle" >Hassan Shakeri (2017) [<xref ref-type="bibr" rid="hanspub.42666-ref12">12</xref>]</td><td align="center" valign="middle" >恰当，随机数字表法</td><td align="center" valign="middle" >恰当</td><td align="center" valign="middle" >不清楚</td><td align="center" valign="middle" >描述了撤出或退出的数目或理由</td><td align="center" valign="middle" >6分</td></tr><tr><td align="center" valign="middle" >P. Borman (2017) [<xref ref-type="bibr" rid="hanspub.42666-ref13">13</xref>]</td><td align="center" valign="middle" >恰当，随机数字表法</td><td align="center" valign="middle" >不清楚，只表明随机数字表法</td><td align="center" valign="middle" >不清楚</td><td align="center" valign="middle" >无撤出与退出</td><td align="center" valign="middle" >4分</td></tr><tr><td align="center" valign="middle" >张娥铿等(2017) [<xref ref-type="bibr" rid="hanspub.42666-ref14">14</xref>]</td><td align="center" valign="middle" >恰当，随机数字表法</td><td align="center" valign="middle" >不清楚，只表明随机数字表法</td><td align="center" valign="middle" >不清楚</td><td align="center" valign="middle" >无撤出与退出</td><td align="center" valign="middle" >4分</td></tr><tr><td align="center" valign="middle" >肖少华等(2019) [<xref ref-type="bibr" rid="hanspub.42666-ref15">15</xref>]</td><td align="center" valign="middle" >不清楚，随机试验但未描述方法</td><td align="center" valign="middle" >不清楚，只表明随机数字表法</td><td align="center" valign="middle" >不清楚</td><td align="center" valign="middle" >描述了撤出或退出的数目或理由</td><td align="center" valign="middle" >4分</td></tr><tr><td align="center" valign="middle" >张禄菊(2019) [<xref ref-type="bibr" rid="hanspub.42666-ref16">16</xref>]</td><td align="center" valign="middle" >不清楚，随机试验但未描述方法</td><td align="center" valign="middle" >不清楚，只表明随机数字表法</td><td align="center" valign="middle" >不恰当</td><td align="center" valign="middle" >描述了撤出或退出的数目或理由</td><td align="center" valign="middle" >3分</td></tr><tr><td align="center" valign="middle" >Fatmanur Aybala Ko&#231;ak (2019) [<xref ref-type="bibr" rid="hanspub.42666-ref17">17</xref>]</td><td align="center" valign="middle" >不清楚，随机试验但未描述方法</td><td align="center" valign="middle" >不清楚，只表明随机数字表法</td><td align="center" valign="middle" >不清楚</td><td align="center" valign="middle" >无撤出与退出</td><td align="center" valign="middle" >3分</td></tr><tr><td align="center" valign="middle" >TGuler (2020) [<xref ref-type="bibr" rid="hanspub.42666-ref18">18</xref>]</td><td align="center" valign="middle" >不清楚，随机试验但未描述方法</td><td align="center" valign="middle" >恰当</td><td align="center" valign="middle" >不清楚</td><td align="center" valign="middle" >描述了撤出或退出的数目或理由</td><td align="center" valign="middle" >5分</td></tr><tr><td align="center" valign="middle" >Nihal Teze l (2020) [<xref ref-type="bibr" rid="hanspub.42666-ref19">19</xref>]</td><td align="center" valign="middle" >不清楚，随机试验但未描述方法</td><td align="center" valign="middle" >不清楚</td><td align="center" valign="middle" >不清楚</td><td align="center" valign="middle" >描述了撤出或退出的数目或理由</td><td align="center" valign="middle" >4分</td></tr><tr><td align="center" valign="middle" >TOzmen (2020) [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>]</td><td align="center" valign="middle" >不清楚，随机试验但未描述方法</td><td align="center" valign="middle" >不清楚</td><td align="center" valign="middle" >不清楚</td><td align="center" valign="middle" >描述了撤出或退出的数目或理由</td><td align="center" valign="middle" >4分</td></tr></tbody></table></table-wrap><p>表2. 纳入研究的质量评估结果</p></sec><sec id="s7_3"><title>3.3. 肌内效贴组和无刺激组(VAS评分)</title><p>共被分别纳入2个模型研究(78例) [<xref ref-type="bibr" rid="hanspub.42666-ref12">12</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref19">19</xref>]，它们的异质性模型测试都表明各个纳入模型研究之间的差异具有显著的异质性(P = 0.05, I<sup>2</sup> = 74%)，然后使用随机化学效应组合模型进行综合分析，整理得合并后的异质性随机效应量约为MD = −1.17，95%CI (−3.06, 0.73)，Z = 1.21，P = 0.23，综合考虑这些差异对于现代统计学的研究影响没有重要科学的意义。如图4。本次纳入文献研究出现明显异质性，可能的原因是由于纳入研究的病程有所差异，Hassan Shakeri [<xref ref-type="bibr" rid="hanspub.42666-ref12">12</xref>] 的病程为平均6个月，而Nihal Tezel [<xref ref-type="bibr" rid="hanspub.42666-ref19">19</xref>] 的病程最长60个月，最低3个月。</p><p>图4. KT与无刺激组改善VAS评分比较的森林图</p></sec><sec id="s7_4"><title>3.4. 肌内效贴组和假刺激组(VAS评分)</title><p>共被纳入7项(例) [<xref ref-type="bibr" rid="hanspub.42666-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref10">10</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref11">11</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref15">15</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref16">16</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref17">17</xref>]，异质性测试结果表明各个研究之间存在着显著的差别(P &lt; 0.00001, I<sup>2</sup> = 93%)。我们进行了异质性的分析，通过观察各研究的干预措施来进行亚组分析，3个研究(162例) [<xref ref-type="bibr" rid="hanspub.42666-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref11">11</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref16">16</xref>] 的干预措施分别是肌内效和超声波，对照组分别是超声波；3个研究(112例) [<xref ref-type="bibr" rid="hanspub.42666-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref10">10</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref15">15</xref>] 的干预措施是超声波肌内效的联合体外冲击波，对照组是体外的冲击波，故采用亚组分析，结果显示仍然存在明显的异质性，超声波亚组P &lt; 0.01，I<sup>2</sup> = 95%，合并效应量MD = −1.29，95% CI (−1.57, −1.01)，Z = 8.93，P &lt; 0.01，差异在数值上有一定的统计学价值和意义，体外冲击波群的P = 0.01，I<sup>2</sup> = 77%，合并效应量MD = −0.23，95% CI (−0.42, −0.05)，Z = 2.46，P = 0.01，差异在数值上有一定的统计学价值和意义。根据观察各项目的基本特点发现疗程之间存在着很大的差异，张禄菊2019 [<xref ref-type="bibr" rid="hanspub.42666-ref16">16</xref>] 的疗程一般为2周，其余两篇均为3周；肖少华2019 [<xref ref-type="bibr" rid="hanspub.42666-ref15">15</xref>] 的疗程时间约为3周，其余两篇均疗程长度为6周，故去除了张禄菊2019 [<xref ref-type="bibr" rid="hanspub.42666-ref16">16</xref>] 和肖少华2019 [<xref ref-type="bibr" rid="hanspub.42666-ref15">15</xref>]，结果表明各个临床研究之间均没有明显的异质性，使用了固定效应模型进行了分析，2个临床研究(112例) [<xref ref-type="bibr" rid="hanspub.42666-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref11">11</xref>] 的异质性检查结果显示P = 0.16，I<sup>2</sup> = 50%，合并有疗效应量MD = −2.02，95% CI (−2.38, −1.65)，Z = 10.82，P &lt; 0.00001，差异具有统计学的意义；2个研究(83例) [<xref ref-type="bibr" rid="hanspub.42666-ref9">9</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref10">10</xref>] 异质性检验表明P = 1.00，I<sup>2</sup> = 0%，合并效应量MD = −0.20，95% CI (−0.39, −0.01)，Z = 2.11，P = 0.03，差异具有统计学的意义。在森林图中，以菱形符号表示合并MD的95%CI，均位于无效竖线的左侧，提示KT在改善VAS评分方面优于假刺激。如图5。</p><p>图5. KT与假刺激改善VAS评分比较的森林图</p></sec><sec id="s7_5"><title>3.5. 肌内效组和理疗组</title><sec id="s7_5_1"><title>3.5.1. VAS评分</title><p>共被纳入3个研究(109例) [<xref ref-type="bibr" rid="hanspub.42666-ref15">15</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref18">18</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>]，3个纳入文献研究的异质性检查结果显示每个研究之间存在着明显的异质性差异(P = 0.0001, I<sup>2</sup> = 85%)，我们对这些纳入文献研究进行了异质性的分析，通过数据分析观察可以发现T Guler 2020 [<xref ref-type="bibr" rid="hanspub.42666-ref18">18</xref>] 病程 &lt; 3个月，与其他纳入文献研究的差异较大；将其去除后剩下的2个研究(69例) [<xref ref-type="bibr" rid="hanspub.42666-ref15">15</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>] 对再次进行了异质性检查，其中TOzmen [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>] 对三组研究进行了比较，干预措施分别为US和ESWT，结果表明三组研究之间均没有明显的异质性(P = 0.57, I<sup>2</sup> = 0%)，然后使用固定效应模型进行分析，整理合并效应量MD = 0.16，95% CI (0.03, 0.28)，Z = 2.47，P = 0.01，发现每个纳入文献研究的差异具有统计学的意义。在森林图中，以一个菱形符号表示合并MD的95% CI，其位于无效率竖线右侧，显示KT在对VAS的评分上不如理疗组。如图6。</p><p>图6. KT与理疗组改善VAS评分比较的森林图</p></sec><sec id="s7_5_2"><title>3.5.2. PRTEE评分</title><p>共被统计纳入2个模型研究(140例) [<xref ref-type="bibr" rid="hanspub.42666-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>]，异质性模型测试检验结果中的检验数据表明各个模型研究之间几乎没有明显的异质性(P = 0.58, I<sup>2</sup> = 0%)，使用了合并固定化学效应量的模型方法进行数值分析，合并固定效应量约为MD = 0.92，95%CI (−0.44, 2.29)，Z = 1.33，P = 0.18，差异几乎没有任何统计学的现实意义。在森林图中，以一个菱形表示合并MD的95%CI，与其他无效的菱形竖线符号交错，提示KT在精神治疗和心理改进效果PRTEE理疗等级上的有效得分与其他理疗等级没有任何本质区别。如图7。</p><p>图7. KT与理疗改善PRTEE评分比较的森林图</p></sec></sec></sec><sec id="s8"><title>4. 讨论</title><p>本研究对肌内效贴布(KT)对肱骨外上炎症治疗效果的相关文献作了一个系统性的评价，从而对kt与其它治疗，包括无刺激、假刺激、理疗和体外冲击波(ESWT)等疗效之间的差异是否具有统计学重要性。通过对系统的分析结果可知，与无刺激、假性刺激和ESWT比较，KT改善了患者肱骨外上腺炎更具优势，但与理疗相比确无差异，可能与纳入该病相关文献的数量相对较少(3篇) [<xref ref-type="bibr" rid="hanspub.42666-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref15">15</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>]，且疗程不一(2篇为2周 [<xref ref-type="bibr" rid="hanspub.42666-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.42666-ref20">20</xref>]，1篇为3周 [<xref ref-type="bibr" rid="hanspub.42666-ref15">15</xref>] )有关，希望以后有更多的此类研究对本结论进行支持和验证。而在功能改善方面，VAS评分结果有显著意义，PRTEE评分结果无显著意义。</p><p>本课题还是存在以下的几个方面局限性：① 文献数量方面：目前对于肌内效贴法治疗肱骨外上膜炎的RCT研究相对较少，被纳入该疾病系统综合评价的研究仅13篇，共706例患者，存在着被纳入该疾病文献的数量和患者样本总数量偏少的问题；② 文献内容方面：只选择了中文和英文两类文献，文章中很多资料可能大概率会出现收录错误的情况；③ 结果参考方面：对于结局性指标的考核评价上，不同的文献采用了不同的衡量量表，评价方法也与之具有一定的差异性；④ 样本环境方面：各个参考文献的各项研究中对于患者的基线水平(包括年龄、疾病)、疗效评分的主观性和以及其他治疗处方(即时间、方式、频率和周期)之间的差别均很有可能会导致其异质性诊断的来源；⑤ 使用方法方面：由于大部分文献中随机序列的产生只是提到了随机的字样，而没有明确产生方式，方案分配的隐藏与受试者、研究人员、结局评估者盲法的具体实施也并没有明确，因此总结出的整体文献质量不高，论证的强度相对较差。这些局限性和异质性都有可能导致本课题分析结果出现偏倚，从而严重影响其结果的准确性。</p></sec><sec id="s9"><title>基金项目</title><p>山东省自然科学基金资助项目(ZR2019BH069)。</p></sec><sec id="s10"><title>文章引用</title><p>黄琬云,宋红宇,贾梦真,张孝刚,姜 影. 肌内效贴布治疗肱骨外上髁炎疗效的系统评价和Meta分析Systematic Evaluation and Meta-Analysis of the Efficacy of Kensiotaping in the Treatment of External Humeral Epicondylitis[J]. 临床医学进展, 2021, 11(05): 2296-2305. https://doi.org/10.12677/ACM.2021.115331</p></sec><sec id="s11"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.42666-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">张进霖, 奚小冰. 非甾体类抗炎药治疗网球肘疗效的Meta分析[J]. 中国循证医学杂志, 2020, 20(9): 1069-1074.</mixed-citation></ref><ref id="hanspub.42666-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Degen, R.M., Conti, M.S., Camp, C.L., et al. (2018) Epidemiology and Disease Burden of Lateral Epicondylitis in the USA: Analysis of 85,318 Patients. HSS Journal, 14, 9-14. &lt;br&gt;https://doi.org/10.1007/s11420-017-9559-3</mixed-citation></ref><ref id="hanspub.42666-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">李富林, 黄宇, 尹东, 黄晓, 莫冰峰. 体外冲击波治疗肱骨外上髁炎的效果评价: 一项短-中期随访[J]. 实用医学杂志, 2020, 36(24): 3369-3372.</mixed-citation></ref><ref id="hanspub.42666-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">黄菁, 欧玲. 穴位注射联合中药内服外敷治疗肱骨外上髁炎的疗效观察[J]. 医学理论与实践, 2020, 33(3): 421-422.</mixed-citation></ref><ref id="hanspub.42666-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">石毓灵, 李光耀, 梁祖建. 多种针刺疗法治疗肱骨外上髁炎的贝叶斯网状Meta分析[J]. 中国组织工程研究, 2020, 24(23): 3756-3763.</mixed-citation></ref><ref id="hanspub.42666-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">余波, 陈文华, 王人卫. 肌内效贴改善运动功能的临床研究现状与思考[J]. 中国运动医学杂志, 2014, 33(3): 275-280.</mixed-citation></ref><ref id="hanspub.42666-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Higgins, J.P. and Green, S. (2008) Cochrane Handbook for Systematic Reviews of Interventions. Wiley-Blackwell, Hoboken. &lt;br&gt;https://doi.org/10.1002/9780470712184</mixed-citation></ref><ref id="hanspub.42666-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">张娥铿, 王晓东. 肌内效贴治疗肱骨外上髁炎的临床观察[J]. 山西医药杂志, 2016, 45(23): 2727-2729.</mixed-citation></ref><ref id="hanspub.42666-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">余波, 陈文华, 王人卫, 瞿强, 祁奇, 乔钧. 肌内效贴联合体外冲击波治疗难治性肱骨外上髁炎的疗效观察[J]. 中华物理医学与康复杂志, 2016, 38(5): 381-383.</mixed-citation></ref><ref id="hanspub.42666-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">李范强, 肖菲娜. KT联合体外冲击波疗法治疗难治性肱骨外上髁炎的可行性分析[J]. 医学理论与实践, 2017, 30(14): 2101-2103.</mixed-citation></ref><ref id="hanspub.42666-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">丁丹阳, 王艳, 裴飞, 刘长辉, 宫双, 金洁. 运动机能贴布联合物理因子治疗肱骨外上髁炎的疗效观察[J]. 中国骨与关节损伤杂志, 2017, 32(7): 95-96.</mixed-citation></ref><ref id="hanspub.42666-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Shakeri, H., Soleimanifar, M., Arab, A.M. and Behbahani, S.H. (2018) The Effects of KinesioTape on the Treatment of Lateral Epicondylitis. Journal of Hand Therapy, 31, 35-41. &lt;br&gt;https://doi.org/10.1016/j.jht.2017.01.001</mixed-citation></ref><ref id="hanspub.42666-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Borman, P., Esmer, A., Nacir, B., Guler, M. and Karagoz, A. (2017) The Efficacy of Kinesi Taping, Local Steroid Injection and Low Level Laser Therapy in Patients with Lateral Epicondylitis. Osteoporosis International, 28, S445.</mixed-citation></ref><ref id="hanspub.42666-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">张娥铿, 程桥珍, 曹学兵, 程伟. 肌内效贴技术在肱骨外上髁炎无创治疗中的应用[J]. 吉林医学, 2017, 38(12): 2227-2230.</mixed-citation></ref><ref id="hanspub.42666-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">肖少华, 覃华生, 李然, 武文平, 朱晓田, 李新通, 曲蕾, 潘玮敏. 双Y形肌内效贴联合体外冲击波治疗运动员肱骨外上髁炎疗效观察[J]. 陕西医学杂志, 2019, 48(6): 702-705, 710.</mixed-citation></ref><ref id="hanspub.42666-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">张禄菊, 罗伦, 周蕴启, 蒋敏, 李娟. 肌内效贴布对早期网球肘患者的疗效观察[J]. 按摩与康复医学, 2019, 10(10): 3-5.</mixed-citation></ref><ref id="hanspub.42666-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Koçak, F.A., Kurt, E.E., Tuncay, S.Ş.F. and Erdem, H.R. (2019) Short-Term Effects of Steroid Injection, Kinesio- Taping or Both on Pain, Grip Strength and Functionality of Patients with Lateral Epicondylitis: A Single-Blinded Randomized Controlled Trial. American Journal of Physical Medicine &amp; Rehabilitation, 98, 751-758.</mixed-citation></ref><ref id="hanspub.42666-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Yildirim, P. and Guler, T. (2020) Comparison of the Efficacy of Kinesio-Taping and Extracorporeal Shock Wave Therapy in Patients with Newly Diagnosed Lateral Epicondylitis: A Prospective Randomized Trial. Nigerian Journal of Clinical Practice, 23, 704-710.</mixed-citation></ref><ref id="hanspub.42666-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Nihal, T., Aslı, C., Özgür, K. and Eda, G. (2020) The Effects of Kinesio-Taping on Wrist Extensor Strength Using an Isokinetic Device in Patients with Chronic Lateral Epicondylitis: A Randomized-Controlled Trial. Turkish Journal of Physical Medicine and Rehabilitation, 66, 60-66. &lt;br&gt;https://doi.org/10.5606/tftrd.2020.3298</mixed-citation></ref><ref id="hanspub.42666-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Özmen, T., et al. (2020) Comparison of the Clinical and Sonographic Effects of Ultrasound Therapy, Extracorporeal Shock Wave Therapy, and Kinesio Taping in Lateral Epicondylitis. Turkish Journal of Medical Sciences, 51, 76-83.  
&lt;br&gt;https://doi.org/10.3906/sag-2001-79</mixed-citation></ref></ref-list></back></article>